Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Eton Pharmaceuticals (ETON) Other Gross PP&E Adjustments (2017 - 2025)

Eton Pharmaceuticals' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $364000.0 for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 246.67% to $364000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $364000.0, a 246.67% increase, with the full-year FY2025 number at $364000.0, up 246.67% from a year prior.
  • Other Gross PP&E Adjustments hit $364000.0 in Q4 2025 for Eton Pharmaceuticals, up from -$1.3 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for ETON hit a ceiling of $364000.0 in Q4 2025 and a floor of -$3.2 million in Q1 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$382650.0 across 5 years, with a median of $104000.0 in 2022.
  • The widest YoY moves for Other Gross PP&E Adjustments: up 246.67% in 2025, down 16600.0% in 2025.
  • Tracing ETON's Other Gross PP&E Adjustments over 5 years: stood at -$1.8 million in 2021, then soared by 106.32% to $112000.0 in 2022, then soared by 113.39% to $239000.0 in 2023, then tumbled by 56.07% to $105000.0 in 2024, then skyrocketed by 246.67% to $364000.0 in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for ETON at $364000.0 in Q4 2025, -$1.3 million in Q3 2025, and -$2.3 million in Q2 2025.